Innoviva
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Innoviva and other ETFs, options, and stocks.About INVA
Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI.
INVA Key Statistics
Stock Snapshot
Innoviva(INVA) stock is priced at $22.18, giving the company a market capitalization of 1.64B. It carries a P/E multiple of 6.88.
On 2026-03-05, Innoviva(INVA) stock moved within a range of $21.97 to $22.51. With shares now at $22.18, the stock is trading +1.0% above its intraday low and -1.4% below the session's peak.
Trading activity shows a volume of 640.88K, compared to an average daily volume of 829.1K.
Over the past 52 weeks, Innoviva(INVA) stock has traded between a high of $25.15 and a low of $16.52.
Over the past 52 weeks, Innoviva(INVA) stock has traded between a high of $25.15 and a low of $16.52.
INVA News
Advertisement Why Innoviva’s latest earnings matter for shareholders Innoviva (INVA) just posted fourth quarter and full year 2025 results, highlighted by hig...
Innoviva, Inc. recently reported fourth-quarter 2025 revenue of US$114.61 million and net income of US$164.15 million, capping a full year in which revenue reac...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.